Morgan Stanley Kamada LTD Transaction History

Morgan Stanley

$1.35 Trillion
Q3 2024

A detailed history of Morgan Stanley transactions in Kamada LTD stock. As of the latest transaction made, Morgan Stanley holds 2,654 shares of KMDA stock, worth $16,003. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,654

Previous 2,660 0.23%

Holding current value

$16,003

Previous $13,000 7.69%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$4.83 - $6.25 $28 - $37	-6 Reduced 0.23%	2,654 $14,000
Q2 2024 Oct 17, 2024	SELL	$4.78 - $5.75 $25,964 - $31,234	-5,432 Reduced 67.13%	2,660 $13,000
Q2 2024 Aug 14, 2024	SELL	$4.78 - $5.75 $25,964 - $31,234	-5,432 Reduced 67.13%	2,660 $13,000
Q1 2024 Oct 17, 2024	BUY	$5.58 - $6.42 $30,310 - $34,873	5,432 Added 204.21%	8,092 $45,000
Q1 2024 Aug 16, 2024	SELL	$5.58 - $6.42 $6,562 - $7,549	-1,176 Reduced 12.69%	8,092 $45,000
Q1 2024 May 15, 2024	SELL	$5.58 - $6.42 $6,562 - $7,549	-1,176 Reduced 12.69%	8,092 $45,000
Q4 2023 Aug 16, 2024	BUY	$4.14 - $6.22 $27,357 - $41,101	6,608 Added 248.42%	9,268 $56,000
Q4 2023 Feb 13, 2024	SELL	$4.14 - $6.22 $3,249 - $4,882	-785 Reduced 7.81%	9,268 $56,000
Q3 2023 Nov 15, 2023	BUY	$4.86 - $5.83 $622 - $746	128 Added 1.29%	10,053 $53,000
Q2 2023 Aug 14, 2023	SELL	$4.48 - $5.53 $318 - $392	-71 Reduced 0.71%	9,925 $52,000
Q1 2023 May 15, 2023	SELL	$4.12 - $5.25 $3,551 - $4,525	-862 Reduced 7.94%	9,996 $46,000
Q4 2022 Feb 14, 2023	SELL	$3.79 - $4.84 $32,408 - $41,386	-8,551 Reduced 44.06%	10,858 $43,000
Q3 2022 Nov 14, 2022	SELL	$4.42 - $5.43 $950 - $1,167	-215 Reduced 1.1%	19,409 $87,000
Q2 2022 Oct 27, 2022	SELL	$4.22 - $5.85 $12,951 - $17,953	-3,069 Reduced 13.52%	19,624 $88,000
Q2 2022 Aug 15, 2022	SELL	$4.22 - $5.85 $12,951 - $17,953	-3,069 Reduced 13.52%	19,624 $88,000
Q1 2022 Oct 27, 2022	BUY	$5.43 - $6.81 $16,664 - $20,899	3,069 Added 15.64%	22,693 $125,000
Q1 2022 May 13, 2022	BUY	$5.43 - $6.81 $602 - $755	111 Added 0.49%	22,693 $125,000
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $926,869 - $1.21 Million	-177,902 Reduced 88.74%	22,582 $149,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $1.05 Million - $1.18 Million	200,484 New	200,484 $1.06 Million

Others Institutions Holding KMDA

# of Institutions

Shares Held

6.48M

Call Options Held

200

Put Options Held

View Full List

About KAMADA LTD

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $270M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

More about KMDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Morgan Stanley, based on Form 13F filings with the SEC.

News

Stay updated on Morgan Stanley with notifications on news.

Account